Utah Medical Products (UTMD) Stock Statistics & Valuation Metrics

Utah Medical Products has a market cap or net worth of $222.23M. The enterprise value is $150.48M.

Market Cap

$222.23M

Enterprise Value

$150.48M

Utah Medical Products has 2,849,041 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

2,849,041

Owned by Insiders

0.68%

Owned by Institutions

34.74%

Utah Medical Products’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 7.60%.

Return on Equity (ROE)

0.09

Return on Assets (ROA)

0.09

Return on Invested Capital (ROIC)

7.60%

Return on Capital Employed (ROCE)

0.10

Revenue Per Employee

263.84K

Profits Per Employee

77.30K

Employee Count

146

Asset Turnover

0.31

Inventory Turnover

2.08

The current PE Ratio of Utah Medical Products is 21.67. Utah Medical Products’s PEG ratio is -3.84.

PE Ratio

21.67

PS Ratio

6.58

PB Ratio

1.87

Price to FCF

30.26

Price to Operating Cash Flow

28.90

PEG Ratio

-3.84

In the last 12 months, Utah Medical Products had revenue of 38.52M and earned 11.29M in profits. Earnings per share was 3.48.

Revenue

38.52M

Gross Profit

22.00M

Operating Income

11.40M

Pretax Income

14.11M

Net Income

11.29M

EBITDA

17.06M

Earnings Per Share (EPS)

3.48

In the last 12 months, operating cash flow was 7.97M and capital expenditures -373,000, giving a free cash flow of 7.60M billion.

Operating Cash Flow

7.97M

Free Cash Flow

7.60M

Free Cash Flow per Share

2.39

Utah Medical Products pays an annual dividend of $0.31, resulting in a dividend yield of 1.71%

Dividend Per Share

$0.31

Dividend Yield

1.71%

Payout Ratio

37.61%

Free Cash Flow Yield

3.37%

Earnings Yield

4.72%

Beta

0.51

52-Week Price Change

24.33%

50-Day Moving Average

72.75

200-Day Moving Average

67.88

Relative Strength Index (RSI)

50.11

Average Volume (3m)

36.38K

Utah Medical Products upcoming earnings date is Feb 02, 2027, TBA (Not Confirmed).

Last Earnings Date

Oct 22, 2026

Next Earnings Date

Feb 02, 2027

Ex-Dividend Date

Jun 17, 2026

Utah Medical Products as a current ratio of 37.62, with Debt / Equity ratio of 0.19%

Current Ratio

37.62

Quick Ratio

34.57

Debt to Market Cap

0.00

Net Debt to EBITDA

-5.01

Interest Coverage Ratio

0.00

In the past 12 months, Utah Medical Products has paid 2.82M in taxes.

Income Tax

2.82M

Effective Tax Rate

0.20

Utah Medical Products EV to EBITDA ratio is 9.42, with an EV/FCF ratio of 18.45.

EV to Sales

4.01

EV to EBITDA

9.42

EV to Free Cash Flow

18.45

EV to Operating Cash Flow

17.59

Utah Medical Products has $85.20M in cash and marketable securities with $180.00K in debt, giving a net cash position of $85.02M billion.

Cash & Marketable Securities

$85.20M

Total Debt

$180.00K

Net Cash

$85.02M

Net Cash Per Share

$29.84

Tangible Book Value Per Share

$33.15

Gross margin is 57.69%, with operating margin of 29.93%, and net profit margin of 30.48%.

Gross Margin

57.69%

Operating Margin

29.93%

Pretax Margin

37.16%

Net Profit Margin

30.48%

EBITDA Margin

42.60%

EBIT Margin

37.16%

The average price target for Utah Medical Products is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

-9.62%

EPS Growth Forecast

―

Smart Score

5

AI Score

75